The Clinical Relevance of Fetal Hemoglobin in IDDM and NIDDM Patients

Kopp, Hans-Peter; Krugluger, Walter; Festa, Andreas; Schernthaner, Guntram

doi:10.2337/diacare.18.6.883

Article navigation

Letters| June 01 1995

The Clinical Relevance of Fetal Hemoglobin in IDDM and NIDDM Patients

Hans-Peter Kopp, MD;

Hans-Peter Kopp, MD

Departments of Medicine I, Rudolfstiftung Hospital

Vienna, Austria

Search for other works by this author on:

This Site

PubMed

Google Scholar

Walter Krugluger, MD;

Walter Krugluger, MD

Laboratory Medicine, Rudolfstiftung Hospital

Vienna, Austria

Search for other works by this author on:

This Site

PubMed

Google Scholar

Andreas Festa, MD;

Andreas Festa, MD

Departments of Medicine I, Rudolfstiftung Hospital

Vienna, Austria

Search for other works by this author on:

This Site

PubMed

Google Scholar

Guntram Schernthaner, MD

Departments of Medicine I, Rudolfstiftung Hospital

Vienna, Austria

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to Hans-Peter Kopp, MD, Department of Medicine I, Rudolfstiftung Hospital, Juchgasse 25, A-1030 Vienna, Austria.

Diabetes Care 1995;18(6):883–884

https://doi.org/10.2337/diacare.18.6.883

PubMed:

7555521

The Clinical Relevance of Fetal Hemoglobin in IDDM and NIDDM Patients

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

The Clinical Relevance of Fetal Hemoglobin in IDDM and NIDDM Patients

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only